Health Trials

Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma

ConditionNodal Marginal Zone Lymphoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorInternational Extranodal Lymphoma Study Group (IELSG)

About this trial

International retrospective observational cohort study aimed to describe a molecular classification for NMZL.

Eligibility criteria

Qualifiers

Male or female adults 18 years or older

Diagnosis of NMZL on lymph node histology after Jan 1st, 2000

Availability of tumor material from lymph node (either frozen or FFPE) collected when the patient was treatment naïve

Availability of the baseline and follow-up annotations

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

International Extranodal Lymphoma Study Group (IELSG)

Lead sponsor

Source ClinicalTrials.gov